PITTSBURGH--(BUSINESS WIRE)--ALung Technologies, Inc., the leading provider of low-flow extracorporeal carbon dioxide removal (ECCO2R) technologies for treating patients with acute respiratory failure, today released its first Year in Review Summary, covering 2014. ALung experienced significant year over year growth in 2014, with utilization of its Hemolung Respiratory Assist System (RAS) increasing three-fold compared to 2013. ALung also experienced strong increases in new customer acquisition, with over 75 hospitals in 19 countries having now treated patients with the Hemolung RAS since its mid-2013 launch.
Hey, check out all the research scientist jobs. Post your resume today!
